Claudin-9 (CLDN9) promotes gastric cancer progression by enhancing the glycolysis pathway and facilitating PD-L1 lactylation to suppress CD8+ T cell anti-tumor immunity

ABSTRACT:

SUBMITTER: Hu X 

PROVIDER: S-EPMC12126740 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature